Genetically enhanced, cord-blood derived immune cells strike B-cell cancers

(University of Texas M. D. Anderson Cancer Center) Immune cells with a general knack for recognizing and killing many types of infected or abnormal cells also can be engineered to hunt down cells with specific targets on them to treat cancer, researchers at The University of Texas MD Anderson Cancer Center report in the journal Leukemia.